TITLE

HIV-1 rebound after anti-retroviral therapy

AUTHOR(S)
Ho, David D.; Zhang, Linqi
PUB. DATE
July 2000
SOURCE
Nature Medicine;Jul2000, Vol. 6 Issue 7, p736
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Compares the genotype of rebounding virus with that in the latent reservoir in HIV-1 patients after highly active anti-retroviral therapy. Genetic technique used to study the relationship; Dynamics of the interplay between productive and latent HIV-1 infection; Control of latent reservoir by immunological manipulations.
ACCESSION #
9435454

 

Related Articles

  • Chapter #4: Controlling HIV and AIDS. Gedatus, Gustav Mark // HIV & AIDS (0-7368-0281-9);2000, p28 

    The chapter focuses on the importance of knowing one's HIV status to control its effects and to protect others from the virus. Testing for HIV can be done confidentially or anonymously for complete privacy. HIV-positive people need to eat right, exercise, get plenty of rest, and avoid tobacco,...

  • Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Elford, J.; Ibrahim, F.; Bukutu, C.; Anderson, J. // Sexually Transmitted Infections;Jun2008, Vol. 84 Issue 3, p176 

    Objective: To examine, by ethnicity, gender and sexual orientation, uptake of antiretroviral treatment among people living with HIV in London. Methods: Between June 2004 and June 2005, 1687 people living with HIV (73% response) receiving treatment and care in North East London National Health...

  • Elvitegravir non-inferior to raltegravir in treatment-experienced patients.  // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p12 

    The article focuses on a study which compared the effectiveness of once-daily elvitegravir and twice-daily raltegravir in treating HIV-1 infected patients.

  • One shot to rid body of HIV. Coghlan, Andy // New Scientist;2/21/2009, Vol. 201 Issue 2696, p8 

    This article states that gene therapies that alter the immune system could free those with HIV infection from a liftime of drugs. Researchers in Germany have announced that they are making progress by altering a patient's own white blood cells to make them resistant to HIV. While still...

  • Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population. López-Cortés, Luis F.; Viciana, Pompeyo; Girón-González, José A.; Romero-Palacios, Alberto; Márquez-Solero, Manuel; Martinez-Perez, Maria A.; López-Ruz, Miguel A.; de la Torre-Lima, Javier; Téllez-Pérez, Francisco; Delgado-Fernández, Marcial; Garcia-Lázaro, Milagros; Lozano, Fernando; Mohamed-Balghata, Mohamed O. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    : Etravirine (ETV) is recommended in combination with a boosted protease inhibitor plus an optimized background regimen for salvage therapy, but there is limited experience with its use in combination with two nucleos(t)ide reverse-transcriptase inhibitors (NRTIs). This multicenter study aimed...

  • Genetic Variability of Hepatitis C Virus (HCV) 5’ Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin. Bukowska-Ośko, Iwona; Pawełczyk, Agnieszka; Perlejewski, Karol; Kubisa, Natalia; Caraballo Cortés, Kamila; Rosińska, Magdalena; Płoski, Rafał; Fic, Maria; Kaźmierczak, Justyna; Popiel, Marta; Ząbek, Piotr; Horban, Andrzej; Radkowski, Marek; Laskus, Tomasz // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Association between hepatitis C virus (HCV) quasispecies and treatment outcome among patients with chronic hepatitis C has been the subject of many studies. However, these studies focused mainly on viral variable regions (E1 and E2) and usually did not include human immunodeficiency virus...

  • HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen. Sungkanuparph, Somnuek; Kiertiburanakul, Sasisopin; Apisarnthanarak, Anucha; Malathum, Kumthorn; Sathapatayavongs, Boonmee // International Journal of STD & AIDS;Dec2007, Vol. 18 Issue 12, p832 

    Non-nucleoside reverse transcriptase inhibitors (NNRTIs) have a longer half-life than nucleoside reverse transcriptase inhibitor (NRTIs). Simultaneous interruption of all drugs exposes the patients to NNRTI monotherapy. This study evaluated HIV-1 genotype after treatment interruption (TI) of...

  • Patient Adherence To HAART Regimens: Challenges For Physician Assistants And Health Care Providers. Day, Marvin // Internet Journal of Academic Physician Assistants;2003, Vol. 3 Issue 1, p42 

    Patients often adhere incompletely and inadequately to highly active antiretroviral therapy (HAART) regimens used in the treatment of HIV infection. This permits the emergence of HIV variants that are resistant to current treatment. The physician assistant often assumes the responsibility for...

  • Early Treatment For HIV Can Boost Survival Significantly. Parham, Marti // Jet;11/17/2008, Vol. 114 Issue 19, p48 

    The article discusses a research study by the University of Washington that found a link between early treatment of HIV and an increased survival rate. The author states that HIV patients who did not receive treatment soon after they were diagnosed were 70% more likely to die than those who...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics